Studies into the Effect of the Tyrosine Kinase Inhibitor Herbimycin A on NF-κB Activation in T Lymphocytes EVIDENCE FOR COVALENT MODIFICATION OF THE p50 SUBUNIT
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The tyrosine kinase inhibitor herbimycin A was found to block NF-kappa B stimulation in response to interleukin-1 and phorbol 12-myristate 13-acetate in EL4.NOB-1 thymoma cells and phorbol 12-myristate 13-acetate in Jurkat T lymphoma cells. The effect appeared not to involve inhibition of tyrosine kinase activation as neither interleukin-1 nor phorbol 12-myristate 13-acetate induced major changes in tyrosine phosphorylation in EL4.NOB-1 or Jurkat cells, respectively. Herbimycin A did not interfere with I kappa B-alpha degradation, and in unstimulated cells, it modified NF-kappa B prior to chemical dissociation with sodium deoxycholate. Because herbimycin A is thiol-reactive, we suspected that the target was the p50 subunit of NF-kappa B, which has a key thiol at cysteine 62. Herbimycin A inhibited DNA binding when added to nuclear extracts prepared from stimulated cells, which were shown to contain high levels of p50. Incubation of herbimycin A with 2-mercaptoethanol attenuated the effect. Herbimycin A was also shown to react directly with p50, blocking its ability to bind to the NF-kappa B consensus sequence. However, a mutant form of p50 in which cysteine 62 was mutated to serine was insensitive to herbimycin A. Finally, we demonstrated that the compound inhibited the expression of interleukin-2 (an NF-kappa B-regulated gene) in EL4.NOB-1 cells. These data therefore suggest that herbimycin A inhibits NF-kappa B by modifying the p50 subunit on cysteine 62 in the NF-kappa B complex, which blocks DNA binding and NF-kappa B-driven gene expression. The results urge caution in the use of herbimycin A as a specific tyrosine kinase inhibitor and suggest that the development of agents that selectively modify p50 may have potential as a means of inhibiting NF-kappa B-dependent gene transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of cysteine62in DNA recognition by the P50 subunit of NF-xB
Matthews, J. R., Kaszubska, W., Turcatti, G., Wells, T. N. C., & Hay, R. T. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.8.1727 · Cited by 147
Cited by
Natarajan, K., Singh, S., Burke, T. R., Grunberger, D., & Aggarwal, B. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9090 · Cited by 1,139
REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN
Dalton, T. P., Shertzer, H. G., & Puga, A. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.67 · Cited by 1,118
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Redox Regulation of NF-kappa B Activation
Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M. G., & Packer, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00501-1 · Cited by 859
Oxidative stress and nuclear factor-κB activation
Bowie, A., & O’Neill, L. A. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00296-8 · Cited by 858
Self-citationKabe, Y., Ando, K., Hirao, S., Yoshida, M., & Handa, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.395 · Cited by 585
Meng, F., & Lowell, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1661 · Cited by 479
Regulated expression of telomerase activity in human T lymphocyte development and activation.
Weng, N. P., Levine, B. L., June, C. H., & Hodes, R. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2471 · Cited by 403
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Sandur, S. K., Ichikawa, H., Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601595200 · Cited by 322
Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2088 · Cited by 316
Bowie, A. G., & O’Neill, L. A. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7180 · Cited by 315
Self-citationChristman, J. W., Lancaster, L. H., & Blackwell, T. S. (1998) · Intensive Care Medicine · doi:10.1007/s001340050735 · Cited by 298
Chaturvedi, M. M., Kumar, A., Darnay, B. G., Chainy, G. B. N., Agarwal, S., & Aggarwal, B. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30129 · Cited by 286
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6800 · Cited by 273
Shishodia, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408093200 · Cited by 259
Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB
Ichiyama, T., Okada, K., Lipton, J. M., Matsubara, T., Hayashi, T., & Furukawa, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02439-7 · Cited by 196
CD28: a signalling perspective
WARD, S. G. (1996) · Biochemical Journal · doi:10.1042/bj3180361 · Cited by 149
Ponnappan, U., Trebilcock, G. U., & Zheng, M.-Z. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00059-x · Cited by 17
Metadata
- Authors
- Mahon, T. M., & O'Neill, L. A. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 270
- Issue
- 48
- Pages
- 28557-28564
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2036849587
- Cited by
- 117
- References
- 1
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.